Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Neurology Morbidity and Mortality Conferences Across US Academic Medical Centers
Practice, Policy, and Ethics
P8 - Poster Session 8 (8:00 AM-9:00 AM)
7-001

To understand Neurology Morbidity and Mortality conference (M&M) practices across US academic medical centers.

While their role has evolved over time, M&M conferences can be used to drive systems improvements that enhance the safety and quality of care. In neurology, little is known about the nature, purpose, or current practice of M&Ms.  We surveyed a sampling of major US academic neurology departments to (1) understand the current role of M&Ms in driving systems improvement and (2) develop a model for best practices.    

An 18-question survey designed to characterize M&M conferences in terms of frequency, structure, content, participants, attendance and outcomes was distributed to 56 academic medical centers via a network of department chairs between April-June 2019.

Survey responses were received from 44 departments (79%).  41 departments (93%) hold M&Ms at least quarterly.  74% of departments restrict discussions to selected adverse events. 95% of departments invite both faculty and trainees, 48% invite nurses, 62% invite medical students, and 38% invite ancillary staff such as therapists.  When compared with other conferences, resident, fellow and faculty attendance is reported as moderate to high by 88% of departments.  Over half of the departments identified conference timing, institutional culture regarding quality and safety, and attendance by department leaders as important factors in improving attendance.  57% employ the just culture algorithm and almost two thirds incorporate root cause analysis (64%).  The majority (69%) reported that, in the last two years, written guidelines or protocols resulted directly from conferences.  M&Ms are used to meet ACGME requirements for residents/fellows in 72% of departments. Only 28% provide risk management CMEs for faculty.  

While many US neurology departments use M&Ms to drive systems improvements, there remains considerable variability across conferences.  There may be opportunities to implement a more standardized agenda to drive improvements in the quality and safety of care.  

Authors/Disclosures
Sophia Ryan, MD
PRESENTER
Dr. Ryan has nothing to disclose.
Kathleen McKee, MD (Intermountain Healthcare) Dr. McKee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceraxis.
No disclosure on file
Aneesh B. Singhal, MD, FÂé¶¹´«Ã½Ó³»­ (Massachusetts General Hospital) An immediate family member of Dr. Singhal has received personal compensation for serving as an employee of Biogen. Dr. Singhal has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Medicolegal Firms. Dr. Singhal has received research support from NIH-NINDS. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving as a Honorarium (Âé¶¹´«Ã½Ó³»­) with Biogen.